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I N 1949, DANIELS^ first reported on scalene node biopsy in the diagnosis of intrathoracic disease. Since then, numerous studies have been published confirming the
value of this procedure, both in the diagnosis and in the assessment of the operability
of bronchogenic carcinoma.
Castleberry' reported that scalene node biopsy had been described under many
synonyms. Included among these are prescalene node biopsy,^'' supraclavicular node
biopsy,*' subclavian node biopsy," cervicomediastinal node biopsy," inferior deep
cervical node biopsy," and deep cervical node biopsy.^ Rarely is identical terminology
used. Yet in all these procedures, the anatomical reference point is the anterior
scalene muscle. It is logical, therefore, that the procedure should be called "scalene
node biopsy."
In Daniels'' original group of five cases, none of the nodes was palpable. Subsequent studies by others have included cases with palpable nodes, indicating that
the so-called scalene nodes, in many instances, were located in the supraclavicular
and cervical chains.
Reports in the literature regarding scalene node biopsy in bronchogenic carcinoma
readily demonstrate the value of the procedure. As shown in Table I , in a total of
728 cases reported between 1949 and 1961 by various authors,'''"'" 257 yielded positive
biopsies. Thus, in 35 per cent of the biopsies there was evidence of extrathoracic
metastases. In Table I I , further analysis of this series shows there were 418 biopsies
of non-palpable nodes reported.'''''''""'"'" In this group, 89 (21 per cent) were
positive. In the remaining 310 biopsies in which nodes were palpable, 168 (54 percent)
were positive.
Biopsy of palpable nodes is an accepted diagnostic procedure when bronchogenic
carcinoma is suspected. There continues to be some debate, however, as to the value
of biopsy of non-palpable nodes in these circumstances. In an attempt to clarify the
value of biopsy of non-palpable nodes in suspected bronchogenic carcinoma, all scalene
node biopsies performed at this hospital over an approximate five year period were
*Pulmonary Division.
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Figure 1
Results of Scalene Node Biopsies. Stippled
areas represent positive biopsies. Numerals
indicate the number of patients in each group—
numerals at the top of each column indicate
the total number of cases in that group;
numerals above stippled area indicate the
number of positive cases.
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Figure 2
Relationship of mediastinal nodes on x-ray to
positive non-palpable scalene nodes. Stippled
area represents positive scalene node biopsies.
Numerals represent the number of patients in
each group.

/\TIONSHIP TO I
WIDENED CARINA j
10
7

52%
4
70%

37%
Total Series

Palpable
Nodes

Non -Palpable
Nodes

Figure 3
Relationship of scalene nodes to widened
carina. Stippled area represents positive scalene node biopsies. Numerals represent the
number of patients in each group.

reviewed. In these patients, a possible correlation between positive non-palpable scalene
nodes and x-ray and bronchoscopic findings also was sought.
MATERIAL

This report is based on 487 scalene node biopsies performed from January, 1954,
to April, 1960. Of this total, 117 were proved cases of bronchogenic carcinoma in
whom scalene node biopsy was done as part of the diagnostic work-up. Since scalene
node biopsy was not a routine procedure in all patients with bronchogenic carcinoma.
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this is not a consecutive series of cases. Although these patients presented in a number
of fashions roentgenographically, no patient in this series presented with only a solitary
peripheral nodule.
RESULTS

As Figure 1 illustrates, of the 117 patients with bronochogenic carcinoma, 48
(41 percent) had positive scalene node biopsies. Of the 53 patients who presented
with palpable nodes, 34 (64 percent) yielded positive biopsies. A positive biopsy
was obtained in 14 (22 percent) of the 64 patients in whom no nodes were palpable.
This group of 117 patients with bronchogenic carcinoma was analyzed further
to determine if any correlation existed between non-palpable nodes and roentgenographic and bronchoscopic findings.
In the group of 64 patients with no palpable nodes, there were 33 in whom
no hilar or mediastinal nodes could be identified on routine postero-anterior and
lateral chest x-rays taken by a high K-V technique. Figure 2 shows the scalene nodes
in this group, although non-palpable, were positive for mahgnancy in six cases (18
percent). In the the remaining 31 patients of this non-palpable node group, mediastinal
nodes were reported on routine chest x-rays; and eight (26 percent) had positive
scalene node biopsies. With chest fluoroscopy and laminography, mediastinal nodes
were demonstrated in five additional cases, making a total of 36 patinets in whom
nodes were seen on some form of x-ray. Of this 36, nine (25 percent) had positive
scalene nodes.
Analysis of the bronchoscopic findings again demonstrated the serious prognostic
significance of a widened carina. As illustrated in Figure 3, there were 21 patients
Table I
Results of Scalene Node Biopsy in Bronchogenic Carcinoma
Date of
Publication
Sept.

1949

Author

Positive
Scalene Nodes

No. of Cases
of Bronch. Ca.

Daniels

2

2

(100%)

3

( 21%)
( 45%.)

1954

Cuykendall

14

June

1955

Skinner

53

24

Dec.

1955

Connar

:y

9

( 31%)

May

1957

Umiker

29

7

( 24%)

June

1957

Horwitz

44

24

( 55%)

Sept.

1957

Schwippert

71

6

Dec.

1958

Cruze

Aug.

1959

Gaurie

Aug.

1959

Perry

Sept.

1959

Higgins

Dec.

1959

March

1961

June

(

8%)

26

( 38%)

65

35

( 54%)

51

31)

( 59%)

208

68

( 33%)

Aikens

38

8

( 21%)

Blair

56

15

( 27%)

Total

728

257

( 35%)

435

MAZUR

AND

BRINKMAN

Figure 4
Comparison of chest x-ray on left, taken with high K-V technique, with one on right, taken with
low K-V technique.

in whom a widened carina was noted on bronchoscopy. Eleven of these (52 percent)
had positive scalene node biopsies. Of the ten of this group who had palpable nodes,
seven biopsies (70 percent) were positive. In the remaining eleven patients in whom
no nodes were palpable, four (37 percent) had positive biopsies.
Histologic diagnoses of the positive biopsies were reviewed. The results are shown
in Table I I I . In the group in whom the biopsied nodes were palpable, twelve (35
percent) were diagnosed as undifferentiated carcinoma, nine (26 percent) as epidermoid
carcinoma, and seven (21 percent) as adenocarcinoma. In the group in whom nodes
were not palpable, six (43 percent) were found to have adenocarcinoma, while in
each of three (21.5 percent) the final diagnosis was undifferentiated carcinoma and
epidermoid carcinoma.
DISCUSSION

Except in special circumstances extrathoracic spread of bronchogenic carcinoma
usually is regarded as a contra-indication to resection of the primary tumor. With
biopsy of non-palpable scalene nodes extrathoracic spread of tumor was demonstrated
in 22 percent of the patients who otherwise would have been subjected to thoracotomy.
Thus biopsy of non-palpable scalene nodes is an important preoperative procedure,
as it may spare one out of five patients a needless thoracotomy.
Table I I
Summary of Biopsies of Reported Cases of Bronchogenic Carcinoma

Palpable nodes
Non-palpable nodes

No. of
Biopsies

Positive
Nodes

310
418

168

54%

89

21%
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Table I I I
Histologic Diagnoses in Patients with Positive Scalene Node Biopsies
Palpable
Nodes

Non-palpable
Nodes

Adenocarcinoma

12
7

(35%)
(21%)

6

(21.5%)
( 43%)

Epidermoid Ca.

9

(26%)

3

(21.5%)

Squamous cell Ca.

2

(6%)

(1

(

0%)

Anaplastic Ca.
Papillary Ca.

3

( 9%)

2

(

14%)

I

(3%)

1)

(

0%)

Undifferentiated Ca.

Total

:;4

3

14

The demonstration of mediastinal nodes on x-ray increased the chance of obtaining
a positive biopsy of non-palpable scalene nodes from 18 to 25 percent. It is of interest
to note that with chest fluoroscopy and laminography, mediastinal nodes were demonstrated in only five additional cases. The high K-V technique* used for routine chest
x-rays, we feel, is responsible for this. In Figure 4, a comparison is made between
a chest x-ray using the high K-V technique with one using a low K-V technique.
In the film taken with the high K-V technique, the soft tissue and bone easily are
distinguishable. The right cardiac border and the bifurcation of the trachea readily
are delineated. In the film taken by the low K-V technique, the soft tissue shadow
and bony structures blend into one another, the right cardiac border is indistinguishable,
and the bifurcation of the trachea is not demonstrable. The high K-V technique is
recommended when chest fluoroscopy and laminography are not available, as by this
means mediastinal nodes were visualized and reported in 86 percent of the patients
in whom hilar and mediastinal nodes subsequently were demonstrated using all forms
of diagnostic x-ray.
The finding of a widened carina on bronchoscopy carries with it an increased
incidence of positive scalene node biopsy.
SUMMARY AND CONCLUSIONS

1. One hundred seventeen cases of proved bronchogenic carcinoma in whom scalene
node biopsy was performed were reviewed. Twenty-two percent of the biopsies
reported on patients with non-palpable nodes were positive.
2. The demonstration of mediastinal nodes on x-ray increased the incidence of
positive non-palpable node biopsy from eighteen to twenty-five percent.
3. A widened carina on bronchoscopy was associated with positive non-palpable
scalene node biopsy in thirty-seven percent of the cases.
4. Information as to the value of scalene node biopsy in the evaluation of a solitary
peripheral pulmonary nodule was not available from this study, but consideration
*In the high K-V technique, 125 to 150 K-V are used. If the film is taken at ten feet, no grid
is used; there is, however, an air gap of six inches. If the film is taken at six feet, a moving
grid is used, and there is no significant air gap between the film and the patient.
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should be given to scalene node biopsy as a routine preoperative procedure i n all
other cases of bronchogenic carcinoma.
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